117 related articles for article (PubMed ID: 21677484)
1. [Clinical efficacy and safety of CPT-11+CDDP therapy as third-line chemotherapy for advanced and recurrent gastric cancer].
Godai TI; Oshima T; Numata M; Fukahori M; Sato T; Makino H; Fujii S; Rino Y; Masuda M; Imada T; Kunisaki C
Gan To Kagaku Ryoho; 2011 Jun; 38(6):945-9. PubMed ID: 21677484
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of low-dose CDDP and CPT-11 therapy as second- or third-line chemotherapy for advanced and recurrent gastric cancer].
Ito S; Takagawa R; Minami Y; Watanabe J; Morita T; Mogaki M; Masui H
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1107-11. PubMed ID: 25248893
[TBL] [Abstract][Full Text] [Related]
3. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
Nishikawa K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T
Eur J Cancer; 2015 May; 51(7):808-16. PubMed ID: 25797356
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of low-dose CDDP and CPT-11 for patients with intestinal type of gastric adenocarcinoma].
Nagahori Y; Nagahori K; Hamaguchi Y; Fukushima T; Masui H; Mogaki M; Abe T
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1555-9. PubMed ID: 18799911
[TBL] [Abstract][Full Text] [Related]
5. [Risk associated with severe hematological toxicity in patients with advanced or recurrent gastric cancer receiving primary combination chemotherapy of cisplatin and S-1 or cisplatin and irinotecan hydrochloride].
Sunaga T; Suzuki S; Harada N; Tanaka S; Hayashi T; Suzuki M
Gan To Kagaku Ryoho; 2009 Apr; 36(4):589-93. PubMed ID: 19381029
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer.
Satoh S; Kawashima K; Matsumoto S; Hasegawa S; Okabe H; Nomura A; Yoshibayashi H; Watanabe G; Nagayama S; Fukushima M; Sakai Y
Chemotherapy; 2007; 53(3):226-32. PubMed ID: 17356271
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer.
Ueda S; Hironaka S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
Gastric Cancer; 2006; 9(3):203-7. PubMed ID: 16952039
[TBL] [Abstract][Full Text] [Related]
8. [A case of recurrent gastric cancer successfully treated by a combination of CPT-11 and CDDP as the third-line chemotherapy].
Tonooka T; Yoshioka S; Wakatsuki K; Kataoka M; Miyazawa K; Oeda Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2354-6. PubMed ID: 23268075
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent gastric cancer with lymph node metastasis successfully treated by CPT-11/CDDP therapy].
Min Kim H; Kimura Y; Kanoh T; Ohnishi T; Tono T; Nakano Y; Yano H; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2011 Apr; 38(4):651-4. PubMed ID: 21498998
[TBL] [Abstract][Full Text] [Related]
10. CPT-11 and cisplatin in the treatment of advanced gastric cancer in Asians.
Lim WT; Lim ST; Wong NS; Koo WH
J Chemother; 2003 Aug; 15(4):400-5. PubMed ID: 12962370
[TBL] [Abstract][Full Text] [Related]
11. [Three successful cases with CPT-11 + CDDP chemotherapy where S-1 failed to respond to recurrent gastric cancer].
Handa R; Iijima S; Doi T; Oshima K; Hoshi M; Makari Y; Miyake Y; Oshima S; Kato T; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2108-10. PubMed ID: 18219914
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of CPT-11 and CDDP chemotherapy for advanced pancreatic cancer].
Takagi K; Kawamoto K; Itoh T
Gan To Kagaku Ryoho; 2012 May; 39(5):847-9. PubMed ID: 22584347
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.
Nakashima K; Hironaka S; Boku N; Onozawa Y; Fukutomi A; Yamazaki K; Yasui H; Taku K; Kojima T; Machida N
Jpn J Clin Oncol; 2008 Dec; 38(12):810-5. PubMed ID: 18988666
[TBL] [Abstract][Full Text] [Related]
14. [A case of advanced gastric cancer treated with neoadjuvant chemotherapy of low-dose CPT-11 + CDDP].
Tadatomo H; Suzuki K; Ando M; Yamashita S; Tanaka K; Maruyama S; Harada Y; Ohnuma S; Sakaniwa N; Koyanagi Y
Gan To Kagaku Ryoho; 2001 Jun; 28(6):821-4. PubMed ID: 11432351
[TBL] [Abstract][Full Text] [Related]
15. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A
Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019
[TBL] [Abstract][Full Text] [Related]
16. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
17. [A case report of bowel obstruction due to peritonitis carcinomatosa using combined administration with CPT-11 and CDDP].
Ohta K; Yoshida K; Tanabe K; Hihara J; Yamaguchi Y; Toge T
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1063-7. PubMed ID: 16044975
[TBL] [Abstract][Full Text] [Related]
18. [Long survival of advanced gastric cancer patient after total gastrectomy and postoperative treatment with S-1 despite S-1+CDDP+CPT-11 causing perforation].
Imai H; Obana N; Iwabuchi T; Satou Y; Ooyauchi M; Igarashi T; Matsumoto H; Sakamoto K
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1185-8. PubMed ID: 18633259
[TBL] [Abstract][Full Text] [Related]
19. [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer].
Sugiyama T; Nishida T; Kataoka A; Imaishi K; Komai K; Ushijima K; Hasuo Y; Ookura N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):827-34. PubMed ID: 8841050
[TBL] [Abstract][Full Text] [Related]
20. [A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer].
Tanaka A; Aragane N; Komiya K; Kawaura F; Fukuno Y; Hayashi S
Gan To Kagaku Ryoho; 2008 Jan; 35(1):49-53. PubMed ID: 18195527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
